AQ Implants
Key Facts
| Invested since | 2011 |
| Based in | Schleswig-Holstein |
About the company
The core competency of AQ Implants GmbH is the endoprosthetic reconstruction of severe and complex defects and anomalies. With the development of innovative implant systems AQ Implants GmbH provides surgeons with various surgical options to reconstruct a wide variety of defects.
Under the brand name REVISIO they offer a complete range of implants for the treatment of revision and tumour cases, from easy revision cases to modular-complex defect treatments.
Do you want to
know more about this company?
AQ Implants in the news
More startups from Life Sciences
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Our G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only …
To the complete profileof Akribion Therapeutics
Lindis Blood Care is developing a medical device to be used in oncology for the operation of tumours in order to open up the possibility of self-blood administration of blood …
To the complete profileof Lindis Blood Care
Exit
Development of antibody conjugate-based cancer therapeutics for solid tumors with high unmet needs that are otherwise difficult to treat Problem: Solid cancers are still very difficult to treat. Most treatments …
To the complete profileof Emergence Therapeutics
mo:re has developed a groundbreaking lab platform, combining automation and software for planning, executing, and analysis of cell culture studies. The user-friendly platform aims to simplify cell culture, making organoids …
To the complete profileof mo:re
Exit
Sierra Sensors is combining state of the art label-free detection with cutting edge microfluidic sample delivery, sensor design, and automation, to supply researchers with high performance analytical biosensors.
To the complete profileof Sierra Sensors
NAVAN, Inc. (NAVAN) is an early-stage private biotechnology company developing a novel, proprietary NanoStraw platform to enable the next generation of cell and gene therapies. A non-viral physical delivery technology, …
To the complete profileof Navan
In order to successfully treat the infected patient, you have to recognize and diagnose most reliably the infecting microbe. Noscendo changes the way infection causative microbes are identified. Through a …
To the complete profileof Noscendo
GS Bavaria is the world‘s first supplier of nano- hard metal materials on industrial scale. Production is extremely cost-efficient, sustainable and comes with minimal energy consumption through our unique bioleaching …
To the complete profileof GS Bavaria
AudioCure Pharma is an innovative clinical-stage pharmaceutical company focused on developing treatments for audiological and neurological disorders with a high unmet medical need. Our small molecules have shown Proof-of-Principle in …
To the complete profileof AudioCure
Umlaut.bio GmbH develops small molecules that are intended to be used as first-in-class therapeutics against a variety of diseases. The focus is on the “umlauts” of the genetic code – …
To the complete profileof Umlaut.bio
AdvanceCOR is a drug-developing biotech company which focuses on personalized medicine in cardiovascular diseases. We concentrate on innovative biologic drugs in acute vascular syndromes and have completed phase 2.
To the complete profileof AdvanceCOR
WISE Srl is a Milan and Berlin-based company developing genuinely novel and minimally-invasive implantable leads for Neuromodulation and Neuromonitoring: highly conformable, stretchable, unbreakable and cheaper to produce.
To the complete profileof WISE